590 results on '"Nohynek, Hanna"'
Search Results
2. “If the nurse tells me this is a good thing, I trust her completely” – Exploring health system enablers of MMR vaccine uptake in the Finnish Somali community: A mixed method study
3. Factors associated with parental Human Papillomavirus (HPV) vaccination intention of daughter: A national survey in Finland
4. Contributors
5. Immunization in Europe
6. Who to vaccinate first? A peek at decision-making in a pandemic
7. High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron
8. Respiratory Syncytial Virus–Associated Hospitalization in Adults With Comorbidities in 2 European Countries:A Modeling Study
9. Impact of the COVID‐19 Pandemic on Influenza Circulation During the 2020/21 and 2021/22 Seasons, in Europe
10. COVID-19 vaccine strategies must focus on severe disease and global equity
11. Relative effectiveness of bivalent boosters against severe COVID-19 outcomes among people aged ≥ 65 years in Finland, September 2022 to August 2023.
12. Hybrid Immunity Improves the Immune Response after the Fourth COVID-19 Vaccine Dose in Individuals with Medical Conditions Predisposing to Severe COVID-19
13. COVID-19 vaccination was a rare potential etiology for cause of death after medicolegal autopsy. A Finnish nationwide study.
14. Tobacco Use and Uptake of COVID-19 Vaccinations in Finland: A Population-Based Study
15. Cohort study design for estimating the effectiveness of seasonal influenza vaccines in real time based on register data : The Finnish example
16. Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study
17. Prevalence of pneumococcal nasopharyngeal colonization and serotypes circulating in Cameroonian children after the 13-valent pneumococcal conjugate vaccine introduction
18. Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study
19. Hybrid immunity improves the immune response after fourth Covid-19 vaccine dose in individuals with medical conditions predisposing to severe Covid-19
20. Factors associated with parental intention to vaccinate their child against influenza, Finland, February to March, 2022: a web-based survey
21. Respiratory syncytial virus infections – recent developments providing promising new tools for disease prevention
22. The prevalence of otitis media in 2–3 year old Cameroonian children estimated by tympanometry
23. Caution before fractionating COVID-19 vaccines
24. Effectiveness of Vaccines and Monoclonal Antibodies Against Respiratory Syncytial Virus: Generic Protocol for Register-Based Cohort Study.
25. Effectiveness of Immunization Products Against Medically Attended Respiratory Syncytial Virus Infection: Generic Protocol for a Test-Negative Case-Control Study.
26. Information nudges for influenza vaccination: Evidence from a large-scale cluster-randomized controlled trial in Finland
27. Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland
28. One health, many interpretations: vaccinating risk groups against H5 avian influenza in Finland.
29. Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020–2022
30. Incidence of SARS-CoV-2 Infection and Factors Associated With Complete COVID-19 Vaccine Uptake Among Migrant Origin Persons in Finland
31. New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic
32. The Finnish decision-making process to recommend a new vaccine: From vaccine research to vaccination policy
33. Decreased incidence of pertussis in young adults after the introduction of booster vaccine in military conscripts: Epidemiological analyses of pertussis in Finland, 1995–2015
34. New perspectives on respiratory syncytial virus surveillance at the national level:lessons from the COVID-19 pandemic
35. Post-marketing safety surveillance for inactivated and live-attenuated Japanese encephalitis vaccines in China, 2008–2013
36. Indirect Impact of Ten-valent Pneumococcal Conjugate Vaccine Program on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland
37. Bivalent booster effectiveness against severe COVID-19 outcomes in Finland, September 2022 — January 2023
38. Incidence of sinus thrombosis with thrombocytopenia—A nation-wide register study
39. Qualitative Insights into Vaccine Uptake of Nursing Staff in Long-Term Care Facilities in Finland
40. Sudden Hearing Loss Following Vaccination Against COVID-19
41. Comparison of microarray-predicted closest genomes to sequencing for poliovirus vaccine strain similarity and influenza A phylogeny
42. Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection
43. Report of the 2nd workshop of the International Collaboration on advanced vaccinology training
44. The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiative
45. Lower incidence of hospital-treated infections in infants under 3 months of age vaccinated with BCG
46. Chapter 75 - Immunization in Europe
47. Safety of immunization during pregnancy: A review of the evidence of selected inactivated and live attenuated vaccines
48. Long-term population impact of infant 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in adults in Finland
49. Incidence of SARS-CoV-2 infection and factors associated with complete COVID-19 vaccine uptake among migrant origin persons in Finland.
50. High secondary attack rate and persistence of SARS-CoV-2 antibodies in household transmission study participants, Finland 2020–2021
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.